CN104544047A - Original orange-flavor buccal tablets prepared from sodium L-ascorbate, and preparation method of buccal tablets - Google Patents
Original orange-flavor buccal tablets prepared from sodium L-ascorbate, and preparation method of buccal tablets Download PDFInfo
- Publication number
- CN104544047A CN104544047A CN201410764281.8A CN201410764281A CN104544047A CN 104544047 A CN104544047 A CN 104544047A CN 201410764281 A CN201410764281 A CN 201410764281A CN 104544047 A CN104544047 A CN 104544047A
- Authority
- CN
- China
- Prior art keywords
- orange
- sodium
- vitamine
- parts
- honey
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 title abstract 4
- 235000019187 sodium-L-ascorbate Nutrition 0.000 title abstract 4
- 239000011755 sodium-L-ascorbate Substances 0.000 title abstract 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 title abstract 2
- 239000007968 orange flavor Substances 0.000 title abstract 2
- 235000012907 honey Nutrition 0.000 claims abstract description 31
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 26
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000011782 vitamin Substances 0.000 claims description 61
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 57
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 56
- 239000011734 sodium Substances 0.000 claims description 55
- 229910052708 sodium Inorganic materials 0.000 claims description 55
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 38
- 229940046011 buccal tablet Drugs 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 26
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 11
- 238000001291 vacuum drying Methods 0.000 claims description 11
- 239000011122 softwood Substances 0.000 claims description 9
- 235000015203 fruit juice Nutrition 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 7
- 235000020985 whole grains Nutrition 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000000047 product Substances 0.000 abstract description 30
- 238000005516 engineering process Methods 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 239000000796 flavoring agent Substances 0.000 abstract description 8
- 235000019634 flavors Nutrition 0.000 abstract description 8
- 238000000465 moulding Methods 0.000 abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 abstract 1
- 230000036449 good health Effects 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 235000019195 vitamin supplement Nutrition 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 42
- 235000019154 vitamin C Nutrition 0.000 description 19
- 239000011718 vitamin C Substances 0.000 description 19
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 17
- 229930003268 Vitamin C Natural products 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000002932 luster Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 235000015205 orange juice Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- -1 ange Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000021068 Western diet Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NITJMAGUTXQPTR-UHFFFAOYSA-N [Cu].[Ca].[Fe] Chemical compound [Cu].[Ca].[Fe] NITJMAGUTXQPTR-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000036649 mental concentration Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001379 nervous effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses original orange-flavor buccal tablets prepared from sodium L-ascorbate, and a preparation method of the buccal tablets. The buccal tablets are prepared from the following raw materials in parts by weight: 500-1500 parts of fresh oranges, 100-300 parts of sodium L-ascorbate, 150-350 parts of isomaltulose, 100-250 parts of Arabic gum, 40-150 parts of honey and 0.5-2 parts of magnesium stearate. The buccal tablets maintain the original taste and flavor of the oranges and enhance the function of the sodium L-ascorbate, thus being a good vitamin supplement and a good health product; the buccal tablets are unique in production technology, good in product molding, simple in technology and easy to operate, and are suitable for industrial production.
Description
Technical field
The invention belongs to field of health care food, relate to a kind of former orange taste vitamine C sodium buccal tablet and preparation technology thereof.
Background technology
Vitamin C is also known as ascorbic acid, it is a kind of water soluble vitamin, there is the function of ascorbic acid disease, maintain the indispensable material of human normal physiological metabolism, there is important physiological function, amino acid and neurotransmission is participated in human body, the synthesis of collagen, it participates in hydroxylation reaction in body, for forming bone, tooth, between connective tissue and non-Epithelial cell, sticky thing institute is required, tooth can be maintained, bone, the normal function of blood vessel, increase the resistivity to disease, it also has the permeability reducing capillary, the function stimulating blood coagulation and the resistant function etc. increased infecting.In all kinds of crowd, have shortage in various degree according to interrelated data report vitamin C, when some indispositions appear in health, just should supplement appropriate vitamin in time and mineral matter improves deficiency disease, especially person in middle and old age should comparatively pay attention to.Vitamin C has prevention effect to numerous disease, the people that in body, vitamin C is high, absorbs the harmful elements such as lead, cadmium, chromium more hardly the people of contaminated environment work; More the people smoked eats and helps containing ascorbic food the resistance improving cell, keeps the elasticity of blood vessel, eliminates the nicotine in body; Be engaged in the people of strenuous exercise and highly intensive labour, these people, because of too much meeting large losses vitamin C of sweating, should be supplemented in time; Vitamin C Wheat Protein, replenishing vitamins C can suppress the generation of pigmented spots, promotes that it disappears; Aspirin, hypnotic, anticancer change medicine, tetracycline, calcium product, contraceptive, depressor etc., all can make body vitamin C reduce, and can cause other bad reaction, should replenishing vitamins C in time.
Vitamin C is clinical basic common drug, be widely used on various diseases prevention and therapy, because vitamin C aqueous ph value is close to about 2, therefore, acidity is comparatively large, orally uses oral cavity, throat esophagus and gastric stimulation comparatively large, unsuitable long-term taking, also be not suitable for taking with acidic drug simultaneously, use is subject to a definite limitation.And vitamine C sodium is ascorbic sodium salt, aqueous ph value is close to neutral, and its effect is identical with ascorbic acid, but owing to being sodium salt, so performance is more stable, no longer include ascorbic highly acid simultaneously, can for a long time and multi-medicament take simultaneously, be more better than vitamin C.Vitamine C sodium belongs to domestic and international widely used vitamin C intensified dose, progressively substitutes vitamin C and uses.
Orange is the fruit of Rutaceae citrus plant orange tree, and fruit peeling can eat its pulp raw, and pulp also can be used as the additives of other foods.Its fruit juice taste is sweet and fragrant, and containing a large amount of sugar and a certain amount of citric acid and abundant vitamin C, nutritive value is higher, fruit also containing citrin, the pharmaceutical value that tool is high.Analyze according to nutritionist, the biotic energy index of orange is 13.8750, and disease prevention index is 132.50.Orange is rich in the active principles such as hesperidine, citric acid, malic acid, butanedioic acid, carbohydrate, pectin and vitamin, nature and flavor acid, cool.Australian Union's science and industrial research tissue find, it can prevent oral cavity, the cancer of esophagus and stomach occurs; It can also make the incidence of apoplexy reduce by 19%, and orange is counted as ascorbic main source of supply in the middle of Western diet traditionally, also can provide the mineral matter such as a considerable amount of carrotene and potassium, calcium, iron.According to another U.S.'s research institution's research display, orange juice can increase the content of HDL in body (HDL), thus reduce the possibility suffered from a heart complaint, because the vitamin C in orange can suppress cholesterol to be converted into bile acid in liver, thus the concentration of bile cholesterol is declined, both assemble the chance also just corresponding minimizing forming gall stone; Dermal melanin calmness can be made to reduce, thus reduce blackspot and freckle, make whitening skin; Contribute to recovering skin elasticity, prevent anaphylactoid generation; The formation of carcinogen can be suppressed, can also soften and protect.In addition, pectin contained in orange peel also can promote that food passes through intestines and stomach, cholesterol is excreted with ight soil quickly, to reduce the absorption of cholesterol, can promote that HDL increases, and the low-density lipoprotein (LDL) transporting " bad " is to external, blood vessel, stimulate circulation, reduce cholesterol and blood fat.Will have a greatly reduced quality iff its health-care effect of extracting orange juice, because in processing orange juice process, the loss of vitamin C, Flavonoid substances and carotenoid is a lot, and other dietary fibers beyond pectin are almost with regard to total loss.
Honey, main component is fructose (molecular formula is C6H12O6), water, and also having trace element and the inorganic salts such as a small amount of copper iron calcium, is the highly finished product of the glucide that honeybee is led in honeycomb, and nature and flavor are sweet, flat, enter lung, spleen, large intestine channel.Have hypotensive, protect the effect such as liver, alleviating pain honey and be not only delicious nutriment, and be treatment various diseases, strong health and the medicine of promoting longevity.Honey is useful especially with the children being easy to the food digested for somagenic need high heat, and it can promote appetite, improves metabolism, people's spirit is good for refreshing and full of physical strength, improves body to the resistance of disease.
Isomaltoketose, because the secretion of insulin can not be caused after its digested absorption, also the activation of LPL activity would not be caused, so the existence of isomaltoketose makes grease be not easy to be absorbed in adipose tissue, isomaltoketose can also improve mental concentration and to releive nervous effect, it can not be caused the microorganism of decayed tooth to utilize by oral cavity, certainly also insoluble polydextrose would not be produced, isomaltoketose not only itself can not cause decayed tooth, more has the decayed tooth effect suppressing to be caused by sucrose.
At present, domestic and international market also has sodium vitamin C formulation to go on the market, mainly the formulation such as capsule, masticatory, lozenge, of less types, and be substantially all add the additive such as essence, pigment, be not suitable for long-term taking, and its composition is more single, and health care is poor.Now be badly in need of a kind of instant of exploitation, be of high nutritive value, easily store and take, and can long-term taking product.Finding by retrieving domestic and international prior art, also not preparing the report of former orange taste vitamine C sodium buccal tablet with orange and vitamine C sodium, honey, isomaltoketose for major ingredient at present.Based on above theoretical and Shortcomings, this patent develops former orange taste vitamine C sodium buccal tablet on the basis solving many technical problems, is of high nutritive value, pure in mouth feel, safe without toxic side effect, and processing technology is relatively simple, produces than being easier to realize industrialization.
Summary of the invention
Content of the present invention is to provide a kind of former orange taste vitamine C sodium buccal tablet of effective, taking convenience, pure taste, and prepares the preparation method of this buccal tablet.This product have ascorbic acid disease, anti-oxidant, antitumor, reduce lipid peroxidation, improve the effects such as immunity of organisms, cough-relieving wet one's whistle, can be used for prevention and supplemental treatment scurvy and various acute and chronic communicate illness or other diseases to strengthen Abwehrkraft des Koepers, after being ill convalescence During Wound Healing and the health therapy of anaphylactia.
The former orange taste vitamine C sodium buccal tablet of the present invention adopts orange fresh goods to squeeze Normal juice, and pomace pulverizes achievement powder after adding isomaltoketose vacuum drying, and it retains the distinctive color of orange and smell, without the need to adding pigment and essence again.Adopt orange juice repeatedly to granulate after orange fruit powder adds honey, Arabic gum, particle adds vitamine C sodium compressing tablet, makes former orange taste vitamine C sodium buccal tablet, the present invention improves product original flavor, mouthfeel and health care, it can make lozenge forming, and outward appearance is beautiful, and mouthfeel is good.
The present invention overcomes correlation technique difficult point by screening science prescription composition and unique preparation technology, by product prepared by this method, both the active ingredient of former orange, local flavor and color and luster had been kept, and improve product medicine and health care value, and vitamine C sodium pH value is close to neutral, it can alleviate acid stimulation, is easy to product and sucks.In prescription of the present invention, primary raw material vitamine C sodium has stronger clinical function, it can be used for a variety of causes and causes vitamin C deficiency to prevent, and also can be used for the treatment of hypovitaminosis C clinical disease, simultaneously because its PH is close to neutral, select it to make buccal tablet mouthfeel better, excitant is less.Granulate owing to directly adopting the sub-Normal juice of orange, it increases the active principle content such as vitamin C, and containing orange primary colors and peculiar fragrance, therefore, without the need to adding pigment and essence in prescription, retain color and luster and the local flavor of former orange greatly, embody the original taste of orange and the smell of product, strengthen Product Safety.Preparation technology of the present invention is easy simultaneously, be applicable to suitability for industrialized production, and product taking convenience safety, effect is good again, genuine, is applicable to all kinds of crowd's long-term taking.
Technical solution of the present invention is:
A kind of former orange taste vitamine C sodium buccal tablet, raw material is made up of the component of following weight portion: the sub-500-1500 part of orange, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
The above former orange taste vitamine C sodium buccal tablet, raw material is preferably made up of the component of following weight portion: the sub-800-1200 part of orange, vitamine C sodium 150-250 part, isomaltoketose 200-300 part, Arabic gum 150-200 part, honey 70-120 part, dolomol 1-1.5 part.
The above former orange taste vitamine C sodium buccal tablet, raw material the best is preferably made up of the component of following weight portion: orange 1000 parts, vitamine C sodium 200 parts, isomaltoketose 150 parts, Arabic gum 175 parts, honey 95 parts, dolomol 1.0 parts.
The preparation method of the above former orange taste vitamine C sodium buccal tablet, comprises the following steps:
1. take raw material by following weight portion: the sub-500-1500 part of orange, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
2. get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice centrifuge or 200-300 mesh filter screen divide gets normal juice, for subsequent use;
3. get above-mentioned orange pomace, add isomaltoketose, mix, be dried to moisture content 3-10%, be ground into compound pomace fine powder, cross 200-300 mesh sieve, obtain compound orange powder;
4. get above-mentioned compound orange powder, add Arabic gum, mix, then add the orange normal juice that honey and step 2 obtain, softwood processed, granulates, and dry, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
The preparation method of the above former orange taste vitamine C sodium buccal tablet, the granulation step in described step 4 preferably adopts multi granulating method: pulverize after making particle drying for the first time, then adopts orange normal juice multi granulating; And particle drying adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
The preparation method of the above former orange taste vitamine C sodium buccal tablet, the orange normal juice obtained in step 2 first can be condensed into appropriate concentrate by the granulation step in described step 4, for granulating.
The preparation method of the above former orange taste vitamine C sodium buccal tablet, described step 3 drying steps preferably adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
In technique of the present invention, orange to be squeezed the juice technology, it can retain the distinctive active ingredient of orange, fragrance and color and luster, and pomace add isomaltoketose drying after adopt micronizer to pulverize, and add honey softwood, the products taste of preparation is fine and smooth, fresh and sweet, more embodies the genuineness of product.Production technology of the present invention is unique, and formed product is good, and technique is simple, easy to operate, can be applicable to suitability for industrialized production.
According to the scientific and reasonable screening auxiliary material of the characteristic of vitamine C sodium and proportioning in the present invention's formula, in order to solve the difficult problem such as preparations shaping and products taste, in preparations shaping, select Arabic gum and honey as combination adhesive, they not only have stronger adhesion strength and soft elasticity, make product color good, outward appearance is beautiful, also has and strengthens product trophic function.Arabic gum is a kind of natural plants hydrosol, and it does not produce heat substantially, is good water-soluble dietary fiber, and medically Arabic gum also has the function reducing Blood Cholesterol; And in order to the mouthfeel of improving product and outward appearance, keep product lubricity and orange fragrance, adopt the honey with good performance of keeping humidity, the moisture that it can make product keep certain, prevent drying, and due to it be nonvolatile polyalcohol, keep the special aromatic function of product so also have, strengthen mouthfeel and the aroma effect of product.Meanwhile, in order to improve, orange is acid and sweet taste inadequate, adopts to add appropriate isomaltoketose sweetener and strengthen mouthfeel and promote the effect of promoting the production of body fluid in this prescription, is conducive to diabetic to take, raising product function.
In order to reach above-mentioned effect, inventor has done a large amount of experiments, and part research conditions is as follows:
One, adhesive screening
In order to solve preparations shaping problem, the adhesives such as dextrin, sodium carboxymethylcellulose, gelatin, slurry glucose, polyvinylpyrrolidone are tried out, but because mouthfeel or granulation and molding effect bad and abandon, finally determine in preparations shaping, to select Arabic gum and honey as combination adhesive, in table 1.
Table 1 adhesive the selection result table (unit: g)
The above results shows, formula 1,7 weak effects, can not be for the production of, and formula 2-6 molding effect is better, and can be used for large production, 4 effects of wherein filling a prescription are best, and mouthfeel is good.
Two, sweetener screening
Sucrose, stevioside, saccharin sodium, xylitol, maltitol etc. have been tried out, in table 2 in test.
Table 2 sweetener the selection result table (unit: g)
Remarks: "+" is more, effect is better.
Above-mentioned result of the test shows, selects isomaltoketose to do sweetener mouthfeel best, gentle fine and smooth.And having certain adhesive effect, hygroscopicity is very low, is beneficial to storage.
In a word, the present invention, by lot of experiments, is preferably applicable to the characteristic supplementary material composition of vitamine C sodium, and prescription composition science, technique is unique, and without the need to adding the industrial chemicals such as pigment, essence, product safety performance is high.By the lozenge that this prescription makes, mouthfeel is good, taking convenience, and retaining orange genuineness and enhance vitamine C sodium function, is a kind of good vitamin replenisher and health products.Meanwhile, easy, the science of prescription composition of the present invention, product bioavilability is high, effective, is applicable to all kinds of crowd's long-term taking.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but do not limit the scope of the invention and range of application:
One, the preparation method of former orange taste vitamine C sodium buccal tablet
Embodiment 1
A preparation method for former orange taste vitamine C sodium buccal tablet, comprises the following steps:
1. take raw material by following weight portion: the sub-50kg of orange, vitamine C sodium 10kg, isomaltoketose 15kg, Arabic gum 10kg, honey 4kg, dolomol 0.05kg.
2. get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice centrifuge divides gets normal juice, for subsequent use;
3. get above-mentioned orange pomace, add isomaltoketose, mix, adopt boulton process 80 DEG C to be dried to moisture content 3%, pulverize with the impact grinding of high energy nanometer, cross 200 mesh sieves, powder not by sieve is pulverized again, after 200 mesh sieves, the superfine powder after sieving is mixed, obtains compound orange powder;
4. get above-mentioned compound orange powder, add Arabic gum, mix, then add the orange normal juice that honey and step 2 obtain, mix softwood processed, granulate, particle 80 DEG C of vacuum drying, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
Embodiment 2
A preparation method for former orange taste vitamine C sodium buccal tablet, comprises the following steps:
1. take raw material by following weight portion: the sub-80kg of orange, vitamine C sodium 15kg, isomaltoketose 20kg, Arabic gum 15kg, honey 7kg, dolomol 0.1kg.
2. get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, for subsequent use;
3. get above-mentioned orange pomace, add isomaltoketose, mix, adopt boulton process 40 DEG C to be dried to moisture content 10%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound orange powder;
4. get above-mentioned compound orange powder, add Arabic gum, mix, then add the orange normal juice that honey and step 2 obtain, mix softwood processed, granulate, particle 40 DEG C of vacuum drying, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
Embodiment 3
A preparation method for former orange taste vitamine C sodium buccal tablet, comprises the following steps:
1. take raw material by following weight portion: the sub-120kg of orange, vitamine C sodium 25kg, isomaltoketose 30kg, Arabic gum 20kg, honey 12kg, dolomol 0.15kg.
2. get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, for subsequent use;
3. get above-mentioned orange pomace, add isomaltoketose, mix, adopt boulton process 60 DEG C to be dried to moisture content 5%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound orange powder;
4. get above-mentioned compound orange powder, add Arabic gum, mix, add the orange normal juice that honey and step 2 obtain again, mix softwood processed, granulate, particle, 60 DEG C of vacuum drying, is pulverized after making particle drying for the first time, then adopts remaining orange normal juice to granulate, until orange normal juice is finished, whole grain, particle adds vitamine C sodium, dolomol, mixes, compressing tablet, to obtain final product.
Embodiment 4
A preparation method for former orange taste vitamine C sodium buccal tablet, comprises the following steps:
1. take raw material by following weight portion: the sub-150kg of orange, vitamine C sodium 30kg, isomaltoketose 35kg, Arabic gum 25kg, honey 15kg, dolomol 0.20kg.
2. get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, and 60 DEG C of reduced pressure concentrations become appropriate concentrate, for subsequent use;
3. get above-mentioned orange pomace, add isomaltoketose, mix, adopt boulton process 60 DEG C to be dried to moisture content 8%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound orange powder;
4. get above-mentioned compound orange powder, add Arabic gum, mix, then add the orange concentrate that honey and step 2 obtain, mix softwood processed, granulate, particle 60 DEG C of vacuum drying, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
Embodiment 5
A preparation method for former orange taste vitamine C sodium buccal tablet, comprises the following steps:
1. take raw material by following weight portion: the sub-100kg of orange, vitamine C sodium 20kg, isomaltoketose 15kg, Arabic gum 17.5kg, honey 9.5kg, dolomol 0.15kg.
2. get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, for subsequent use;
3. get above-mentioned orange pomace, add isomaltoketose, mix, adopt boulton process 50 DEG C to be dried to moisture content 6%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound orange powder;
4. get above-mentioned compound orange powder, add Arabic gum, mix, add the orange normal juice that honey and step 2 obtain again, mix softwood processed, granulate, particle, 50 DEG C of vacuum drying, is pulverized after making particle drying for the first time, then adopts remaining orange normal juice to granulate, until orange normal juice is finished, whole grain, particle adds vitamine C sodium, dolomol, mixes, compressing tablet, to obtain final product.
Two, subjective appreciation
By above-mentioned 5 the embodiment samples prepared, allow 50 people foretaste respectively, carry out sense organ investigation evaluation.Evaluation project has: lozenge structural state, color and luster, local flavor, mouthfeel, and recycling weighting method calculates total score, and structural state weight coefficient is 0.2, and color and luster weight coefficient is 0.2, and local flavor weight coefficient is 0.3, mouthfeel weight coefficient, and 0.3, the results are shown in Table 3.
Table 3 buccal tablet results of sensory evaluation table
Above-mentioned result of the test shows, 5 embodiment samples that the present invention prepares, and subjective appreciation is effective, and weight score is more than 7 points.Illustrate that the present invention can retain the distinctive active ingredient of orange, fragrance and color and luster, and pomace add isomaltoketose drying after adopt micronizer to pulverize, and add honey softwood, the products taste of preparation is fine and smooth, fresh and sweet, retaining orange genuineness and enhance vitamine C sodium function, is a kind of good vitamin replenisher and health products; Adopt orange normal juice multi granulating, and particle drying adopts vacuum drying method, the buccal tablet fragrance obtained is stronger, and rate of drying is also very fast.Production technology of the present invention is unique, and formed product is good, and technique is simple, easy to operate, can be applicable to suitability for industrialized production.
Claims (6)
1. a former orange taste vitamine C sodium buccal tablet, it is characterized in that, raw material is made up of the component of following weight portion: the sub-500-1500 part of orange, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
2. former orange taste vitamine C sodium buccal tablet according to claim 1, it is characterized in that, raw material is made up of the component of following weight portion: the sub-800-1200 part of orange, vitamine C sodium 150-250 part, isomaltoketose 200-300 part, Arabic gum 150-200 part, honey 70-120 part, dolomol 1-1.5 part.
3. former orange taste vitamine C sodium buccal tablet according to claim 1, it is characterized in that, raw material is made up of the component of following weight portion: orange 1000 parts, vitamine C sodium 200 parts, isomaltoketose 150 parts, Arabic gum 175 parts, honey 95 parts, dolomol 1.0 parts.
4. a preparation method for former orange taste vitamine C sodium buccal tablet as claimed in claim 1, is characterized in that, comprise the following steps:
(1) raw material is taken by following weight portion: the sub-500-1500 part of orange, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
(2) get orange, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice centrifuge or 200-300 mesh filter screen divide gets normal juice, for subsequent use;
(3) get above-mentioned orange pomace, add isomaltoketose, mix, be dried to moisture content 3-10%, be ground into compound pomace fine powder, cross 200-300 mesh sieve, obtain compound orange powder;
(4) get above-mentioned compound orange powder, add Arabic gum, mix, then add the orange normal juice that honey and step (2) obtain, softwood processed, granulates, dry, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
5. the preparation method of former orange taste vitamine C sodium buccal tablet according to claim 4, it is characterized in that, granulation step in described step (4) adopts multi granulating method: pulverize after making particle drying for the first time, then adopt orange normal juice multi granulating; And particle drying adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
6. the preparation method of former orange taste vitamine C sodium buccal tablet according to claim 4, is characterized in that, described step (3) drying steps adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764281.8A CN104544047B (en) | 2014-12-11 | 2014-12-11 | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764281.8A CN104544047B (en) | 2014-12-11 | 2014-12-11 | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104544047A true CN104544047A (en) | 2015-04-29 |
| CN104544047B CN104544047B (en) | 2016-08-24 |
Family
ID=53061969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410764281.8A Expired - Fee Related CN104544047B (en) | 2014-12-11 | 2014-12-11 | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104544047B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373479A (en) * | 2017-06-21 | 2017-11-24 | 防城港圣保堂制药有限公司 | A kind of ion VC compositions containing navel orange and preparation method thereof |
| CN107455699A (en) * | 2017-08-11 | 2017-12-12 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing pawpaw and preparation method thereof |
| CN107496645A (en) * | 2017-08-11 | 2017-12-22 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing Chinese yam and preparation method thereof |
| CN108175104A (en) * | 2018-01-18 | 2018-06-19 | 广东健林生物科技有限公司 | A kind of homovitamin C content chewable tablets and preparation method thereof |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1546061A (en) * | 2003-12-12 | 2004-11-17 | 黄爱强 | Vitamin C sodium capsule |
| CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
| CN102178216A (en) * | 2010-12-08 | 2011-09-14 | 叶建斌 | Formula of fruit chewable tablet for antiallergic skin care and preparation method thereof |
| CN102228180A (en) * | 2011-07-12 | 2011-11-02 | 中国热带农业科学院椰子研究所 | Betelnut buccal tablet and preparation method thereof |
| CN102429150A (en) * | 2011-12-15 | 2012-05-02 | 广东汤臣倍健生物科技股份有限公司 | Vitamin C chewable tablets for enhancing human immunity |
| WO2013055047A1 (en) * | 2011-10-13 | 2013-04-18 | (주) 헬스페이스 | Method for extracting korean raspberry, and methods for manufacturing a beverage and a tablet containing korean raspberry |
| CN103110105A (en) * | 2012-11-14 | 2013-05-22 | 江苏江山制药有限公司 | Production method for food additive sugar-free vitamin C sodium salt particles |
| CN103190620A (en) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | Vitamin C lozenge and preparation method thereof |
| KR20140012911A (en) * | 2013-11-29 | 2014-02-04 | 농업회사법인 주식회사 헬스페이스 | Method for extracting rubus coreanus miquel, method for preparing drink and tablet containing the same |
| CN103652939A (en) * | 2012-08-30 | 2014-03-26 | 高宜 | Capsule with multiple vitamins C |
| CN103750182A (en) * | 2013-12-05 | 2014-04-30 | 福建南海食品有限公司 | Honey pomelo powder buccal tablet and preparation method thereof |
| CN103960611A (en) * | 2014-05-06 | 2014-08-06 | 恩施州益寿果业股份有限公司 | Compound kiwi fruit buccal tablet rich in vitamins C and preparing method |
-
2014
- 2014-12-11 CN CN201410764281.8A patent/CN104544047B/en not_active Expired - Fee Related
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1546061A (en) * | 2003-12-12 | 2004-11-17 | 黄爱强 | Vitamin C sodium capsule |
| CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
| CN102178216A (en) * | 2010-12-08 | 2011-09-14 | 叶建斌 | Formula of fruit chewable tablet for antiallergic skin care and preparation method thereof |
| CN102228180A (en) * | 2011-07-12 | 2011-11-02 | 中国热带农业科学院椰子研究所 | Betelnut buccal tablet and preparation method thereof |
| WO2013055047A1 (en) * | 2011-10-13 | 2013-04-18 | (주) 헬스페이스 | Method for extracting korean raspberry, and methods for manufacturing a beverage and a tablet containing korean raspberry |
| CN102429150A (en) * | 2011-12-15 | 2012-05-02 | 广东汤臣倍健生物科技股份有限公司 | Vitamin C chewable tablets for enhancing human immunity |
| CN103652939A (en) * | 2012-08-30 | 2014-03-26 | 高宜 | Capsule with multiple vitamins C |
| CN103110105A (en) * | 2012-11-14 | 2013-05-22 | 江苏江山制药有限公司 | Production method for food additive sugar-free vitamin C sodium salt particles |
| CN103190620A (en) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | Vitamin C lozenge and preparation method thereof |
| KR20140012911A (en) * | 2013-11-29 | 2014-02-04 | 농업회사법인 주식회사 헬스페이스 | Method for extracting rubus coreanus miquel, method for preparing drink and tablet containing the same |
| CN103750182A (en) * | 2013-12-05 | 2014-04-30 | 福建南海食品有限公司 | Honey pomelo powder buccal tablet and preparation method thereof |
| CN103960611A (en) * | 2014-05-06 | 2014-08-06 | 恩施州益寿果业股份有限公司 | Compound kiwi fruit buccal tablet rich in vitamins C and preparing method |
Non-Patent Citations (1)
| Title |
|---|
| 陈武等: "绞股蓝口含片的制备技术", 《食品与机械》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107373479A (en) * | 2017-06-21 | 2017-11-24 | 防城港圣保堂制药有限公司 | A kind of ion VC compositions containing navel orange and preparation method thereof |
| CN107455699A (en) * | 2017-08-11 | 2017-12-12 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing pawpaw and preparation method thereof |
| CN107496645A (en) * | 2017-08-11 | 2017-12-22 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing Chinese yam and preparation method thereof |
| CN108175104A (en) * | 2018-01-18 | 2018-06-19 | 广东健林生物科技有限公司 | A kind of homovitamin C content chewable tablets and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104544047B (en) | 2016-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN104605224A (en) | Original pineapple flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN101023802A (en) | Series products of all-nutrient green health-care bean vermicellic and instant bean vermicellic and preparing method | |
| CN104546955A (en) | Raw kiwifruit flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN105494844A (en) | Production method of Chinese wolfberry fruit tablet candy | |
| CN104544047B (en) | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof | |
| CN107303280A (en) | Okra chews tablet composition and preparation method thereof | |
| CN101095490A (en) | Method for preparation of flavored chickpea bolus | |
| CN102771719B (en) | Preparation technology of black tea pearl rice | |
| CN102132821A (en) | Formula nutritious rice and preparation method | |
| KR20170142756A (en) | composition and method thereof | |
| CN104544048A (en) | Buccal tablet with composite vitamin C sodium and preparation method thereof | |
| CN107751778A (en) | A kind of high microsteping content health caring noodles with effects for removing toxic heat and preparation method thereof | |
| CN101248871A (en) | Lowing blood sugar, blood pressure, blood fat biological food product containing jade substance component | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN104544049A (en) | Vitamin C sodium lozenge and preparation process thereof | |
| CN107432343A (en) | A kind of jasmine tea beverage and preparation method thereof | |
| CN105994740A (en) | Green tea with dendrobium officinale and method for preparing green tea | |
| CN104605223A (en) | Original strawberry flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN108902972A (en) | A kind of lithocarpus litseifolius chewable tablets and preparation method thereof | |
| CN104705565A (en) | Method for preparing three-high (high blood lipid, high blood pressure and high blood sugar) prevention dietary therapy rice | |
| CN105166620A (en) | Horseradish tree composition capable of reducing blood lipid and preparation method of horseradish tree composition | |
| CN103125931A (en) | Novel energy replenisher | |
| CN104305229B (en) | A kind of stem of noble dendrobium dietary fiber food and its processing method | |
| CN104544114A (en) | Multivitamin buccal tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160720 Address after: 530000 Guangxi Nanning Qingxiu District 24 building room 2110 Applicant after: GUANGXI NANNING ZHICUI TECHNOLOGY CONSULTING CO., LTD. Address before: Lake 530022 Nanning Road, No. 4 the Guangxi Zhuang Autonomous Region Lake District 38 Building 2 unit 101 room Applicant before: Zhang Shenman Applicant before: Wei Lingju |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ding Xiangdong Inventor before: Zhang Shenman Inventor before: Wei Lingju |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170524 Address after: Yao Chong Street Road in Qixia District of Nanjing city of Jiangsu Province, No. 1 210046 Patentee after: Jiangsu Handian biological Polytron Technologies Inc Address before: 530000 Guangxi Nanning Qingxiu District 24 building room 2110 Patentee before: GUANGXI NANNING ZHICUI TECHNOLOGY CONSULTING CO., LTD. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20181211 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |